| Name | Title | Contact Details |
|---|
Care Net is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cypress Palms welcomes you to our unique senior living community that offers everything you need and want in Assisted Living. From vibrant social programs and amenities that delight and entertain our residents to exceptional dining, abundant services and compassionate care; a great lifestyle tailored to your needs awaits you here.
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Bacharach Institute and Rehabilitation is a Pomona, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cor is a powerful general wellness product that delivers personalized health insights from a single drop of blood. The Cor Reader uses patented vibrational spectroscopic technology to analyze a surface-level blood sample and report overall trends. The Cor App then delivers key insights and lifestyle improvement recommendations related to indicators such as cholesterol, fasting blood glucose, inflammation and triglycerides. Cor was founded in 2014 by Bob Messerschmidt and is backed by world-class medical advisors from Stanford, UCSF and Duke University.